A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function

NCT01222455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Healthy Volunteers
Pharmacokinetics
Amount of R406 in Blood

Interventions

DRUG: Fostamatinib

Sponsor

AstraZeneca